LOS GATOS, Calif., Feb. 28 /PRNewswire/ -- TriCipher, a leading provider of Internet identity services, today announced a hosted, on-demand version of its powerful digital signature solution. myOneLogin SignatureBook is an on-demand service that accelerates and streamlines business processes requiring non-repudiable signatures across different groups, organizations or geographic locations. It supports a number of different online credentials, including a clientless credential and the SAFE-BioPharma digital signature widely adopted in healthcare and pharmaceutical industries.
"The SAFE-BioPharma® signature standard provides a high level of trust assurance for digital identities, and is instrumental to speeding processes and reducing costs in the healthcare and pharmaceutical industries," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. "The TriCipher myOneLogin SignatureBook service offers SAFE-BioPharma members a means of improving business process and simplifying the signing process. This service will be especially attractive to the growing body of smaller companies which have joined SAFE-BioPharma as a step toward improving their workflows and converting to paperless operations."
myOneLogin SignatureBook collects digital signatures on an electronic document, automatically applying signature policies and streamlining processes of collecting and validating signatures. It creates an original, signed version of a final document as well as a flattened PDF without active signature blocks, suitable for distribution. As an on-demand service, myOneLogin SignatureBook is easy to deploy, and is particularly useful for organizations with many business processes requiring signatures by multiple parties. The service offers several different signature methods, including a TriCipher clientless credential and with credentials compliant with the SAFE-BioPharma digital signature standard. myOneLogin SignatureBook is the in-the-cloud, hosted version of the on-premise TriCipher mySignatureBook digital signing solution.
"Digital signatures are a natural extension of the Internet identity services that we provide at TriCipher, making it easier and more secure to do business on the web," said John De Santis, chairman and CEO at TriCipher. "The on-premise TriCipher mySignatureBook solution is already adopted in large pharmaceutical organizations. By offering these capabilities as an on-demand service, we deliver on the promise of digital signatures for a wider range of businesses."
For more information, please visit www.myOneLogin.com.
TriCipher, Inc. provides Internet identity services to protect web and enterprise portals, the people that use them and the business processes that flow through them against fraud and identity theft. TriCipher myOneLogin™ is the first secure, on-demand offering that delivers strong authentication, single sign-on (SSO) and federation capabilities for web applications in a single solution. The TriCipher Armored Credential System™ (TACS) is a unified authentication system that enables companies to deploy and manage multiple types of credentials from a single infrastructure. Through this flexible "Authentication Ladder," TriCipher protects customer investment by adjusting authentication strength to defeat new threats and to meet regulatory changes without the need to implement a new infrastructure. Founded in 2000, TriCipher is headquartered in Los Gatos, Calif. The company is funded by ArrowPath Venture Capital, EPIC Ventures, Intel Capital, RBC Technology Ventures, and Trident Capital.
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
SOURCE TriCipherBack to top
Copyright©2010 PR Newswire.
All rights reserved